Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients

This study aimed to use non-invasive methods to assess and compare the levels of oxidative indices and non-enzymatic antioxidants in breast and colorectal cancer (CRC) patients. Various studies have reported on lipid peroxidation, hydrogen peroxide (H(2)O(2)) and ferric-reducing antioxidant power (F...

Full description

Saved in:
Bibliographic Details
Main Authors: Chandramathi, S., Suresh, K., Anita, Z.B., Kuppusamy, U.R.
Format: Article
Language:en
Published: 2009
Subjects:
Online Access:http://eprints.um.edu.my/8191/1/Chandramathi-2009-Comparative_assessme.pdf
http://eprints.um.edu.my/8191/
http://link.springer.com/content/pdf/10.1007%2Fs00432-008-0462-7.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1831447551615696896
author Chandramathi, S.
Suresh, K.
Anita, Z.B.
Kuppusamy, U.R.
author_facet Chandramathi, S.
Suresh, K.
Anita, Z.B.
Kuppusamy, U.R.
author_sort Chandramathi, S.
building UM Library
collection Institutional Repository
content_provider Universiti Malaya
content_source UM Research Repository
continent Asia
country Malaysia
description This study aimed to use non-invasive methods to assess and compare the levels of oxidative indices and non-enzymatic antioxidants in breast and colorectal cancer (CRC) patients. Various studies have reported on lipid peroxidation, hydrogen peroxide (H(2)O(2)) and ferric-reducing antioxidant power (FRAP) levels in the serum of cancer patients but this is the first report that highlights the significance of urinary-advanced oxidative protein product (AOPP) in cancer patients. The levels of advanced oxidative protein product (AOPP), hydrogen peroxide (H(2)O(2)), malondialdehyde (MDA) which is a marker for lipid peroxidation and ferric-reducing antioxidant power (FRAP) were measured in urine samples of breast (n = 101) and colorectal cancer (n = 49) patients attending the Oncology Clinic, University Malaya Medical Centre, Kuala Lumpur and were compared with 95 age-matched healthy individuals. AOPP, H(2)O(2) and MDA levels in the urine were significantly higher in the CRC patients compared to the control subjects and breast cancer patients. In breast cancer patients, only AOPP level was elevated. FRAP level did not differ between breast and colorectal cancer patients but the levels were significantly lower compared to control subjects. Urinary oxidative indices such as AOPP, H(2)O(2), and MDA as well as FRAP could serve as useful non-invasive oxidative stress markers in colorectal cancer but only AOPP serves as a useful urinary oxidative biomarker in breast cancer.
format Article
id my.um.eprints-8191
institution Universiti Malaya
language en
publishDate 2009
record_format eprints
spelling my.um.eprints-81912013-12-10T04:25:56Z http://eprints.um.edu.my/8191/ Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients Chandramathi, S. Suresh, K. Anita, Z.B. Kuppusamy, U.R. R Medicine This study aimed to use non-invasive methods to assess and compare the levels of oxidative indices and non-enzymatic antioxidants in breast and colorectal cancer (CRC) patients. Various studies have reported on lipid peroxidation, hydrogen peroxide (H(2)O(2)) and ferric-reducing antioxidant power (FRAP) levels in the serum of cancer patients but this is the first report that highlights the significance of urinary-advanced oxidative protein product (AOPP) in cancer patients. The levels of advanced oxidative protein product (AOPP), hydrogen peroxide (H(2)O(2)), malondialdehyde (MDA) which is a marker for lipid peroxidation and ferric-reducing antioxidant power (FRAP) were measured in urine samples of breast (n = 101) and colorectal cancer (n = 49) patients attending the Oncology Clinic, University Malaya Medical Centre, Kuala Lumpur and were compared with 95 age-matched healthy individuals. AOPP, H(2)O(2) and MDA levels in the urine were significantly higher in the CRC patients compared to the control subjects and breast cancer patients. In breast cancer patients, only AOPP level was elevated. FRAP level did not differ between breast and colorectal cancer patients but the levels were significantly lower compared to control subjects. Urinary oxidative indices such as AOPP, H(2)O(2), and MDA as well as FRAP could serve as useful non-invasive oxidative stress markers in colorectal cancer but only AOPP serves as a useful urinary oxidative biomarker in breast cancer. 2009 Article PeerReviewed application/pdf en http://eprints.um.edu.my/8191/1/Chandramathi-2009-Comparative_assessme.pdf Chandramathi, S. and Suresh, K. and Anita, Z.B. and Kuppusamy, U.R. (2009) Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. Journal of Cancer Research and Clinical Oncology, 135 (2). pp. 319-323. ISSN 0171-5216, DOI https://doi.org/10.1007/s00432-008-0462-7 <https://doi.org/10.1007/s00432-008-0462-7>. http://link.springer.com/content/pdf/10.1007%2Fs00432-008-0462-7.pdf 10.1007/s00432-008-0462-7
spellingShingle R Medicine
Chandramathi, S.
Suresh, K.
Anita, Z.B.
Kuppusamy, U.R.
Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title_full Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title_fullStr Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title_full_unstemmed Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title_short Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
title_sort comparative assessment of urinary oxidative indices in breast and colorectal cancer patients
topic R Medicine
url http://eprints.um.edu.my/8191/1/Chandramathi-2009-Comparative_assessme.pdf
http://eprints.um.edu.my/8191/
http://link.springer.com/content/pdf/10.1007%2Fs00432-008-0462-7.pdf
url_provider http://eprints.um.edu.my/